MRI in multiple sclerosis: Correlation with expanded disability status scale (EDSS)

Multiple Sclerosis

Volumn 5, Issue 4, 1999, Pages 283-286

  Barkhof, Frederik ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Expanded disability status scale; Magnetic resonance imaging; Multiple sclerosis

Indexed keywords

GADOLINIUM; MYELIN;

CONFERENCE PAPER; CONTRAST ENHANCEMENT; CORRELATION FUNCTION; DISABILITY; DISEASE COURSE; HUMAN; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; RELAPSE; REMISSION; REMYELINIZATION;

EID: 0001710321     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/135245859900500415     Document Type: Conference Paper

References (35)

1. Lumsden CE. (1970) The neuropathology of multiple sclerosis. In: Vinken PJ, Bruyn GW, eds. Handbook of Clinical Neurology, Vol. 9. Amsterdam: North-Holland Publishing Company, pp 217-309.
2. Noseworthy JH et al. (1990) Interrater variability with the Expanded Disability Status Scale (EDSS) and Function Systems (FS) in a multiple sclerosis trial. Neurology 110: 971-975.
3. Trapp BD et al. (1998) Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338: 278-285.
4. Bruck W et al. (1997) Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 42: 783-793.
5. Katz D et al. (1993) Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol 34: 661-669.
6. Nebit GM et al. (1991) Multiple sclerosis: histopathological and MR and/or CT correlation in 37 cases at biopsy and three at autopsy. Radiology 180: 467-474.
7. van Waesberghe JH et al. (1998) Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. AJNR Am J Neuroradiol 19: 675-683.
8. van Walderveen MAA et al. (1999) Degree of inflammatory activity only partially predicts development of hypointense lesion on T1 weighted spin echo magnetic resonance images in multiple sclerosis: a long term follow-up study. Archives of Neurology in press.
9. Khoury SJ et al. (1994) Longitudinal MRI in multiple sclerosis: correlation between disability and lesion burden. Neurology 44: 2120-2124.
10. Smith ME et al. (1993) Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetat dimeglumin-enhancing magnetic resonance imaging lesions. Ann Neurol 33: 480-489.
11. Lycklama à Nijeholt GJ et al. (1998) Brain and spinal cord abnormalities in multiple sclerosis: correlation between MR parameters, clinical subtypes and symptomatology. Brain 121: 687-697.
12. Stone LA et al. (1995) Blood-brain barrier disruption on contrast-enhanced MRI in patients with mild relapsing-remitting multiple sclerosis: relationship to course, gender and age. Neurology 45: 1122-1126.
13. Barkhof F et al. (1992) A correlative triad of gadolinium-DTPA MRI, EDSS, and CSF-MBP in relapsing/remitting multiple sclerosis patients treated with high dose intravenous methylpredinsolone. Neurology 42: 63-67.
14. Youl BD et al. (1991) The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits. Brain 114: 2437-2450.
15. Kidd D et al. (1996) MRI dynamics of brain and spinal cord in progressive multiple sclerosis. J Neurol Neurosurg Psych 60: 15-19.
16. Kappos L et al. (1999) Predictive value of gd-enhanced MRI for relapse-rate and changes in disability/impairment in MS: A meta analysis. The Lancet 1999; 353 (g157): gbu-gbg.
17. Losseff NA et al. (1996) Clinical and magnetic resonance imaging predictors of disability in primary and secondary progressive multiple sclerosis. Multiple Sclerosis 1: 218-222.
18. Truyen L et al. (1997) Specific power calculations for magnetic resonance imaging (MRI) in monitoring active relapsing-remitting multiple sclerosis (MS): implications for phase II therapeutic trials. Multiple Sclerosis 2: 283-290.
19. Jacobs LD, et al. (1996) The Multiple Sclerosis Collaborative Research Group (MSCRG). Intramuscular interferon beta-as for disease progression in relapsing multiple sclerosis. Ann Neurol 39: 285-294.
20. Paty DW, Li DKB. (1993) Interferon beta 1-b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicentre, randomized, double-blind, placebo-controlled trial. Neurology 43: 662-667.
21. PRISMS Study Group. (1998) Randomized, double-blind, placebo-controlled study of interferon B-1a in relapsing/ remitting multiple sclerosis. Lancet 352: 1498-1504.
22. Li DKB, Paty D, U.B.C. MS/MRI Analysis Research Group and the PRISMS Study Group. (1999) Randomized, double-blind, placebo-controlled study of interferon-beta 1a in relapsing-remitting multiple sclerosis. Ann Neurol, in press.
23. European Study Group. (1998) In Interferon β-1b in treatment of secondary progressive multiple sclerosis. The Lancet 352: 1491-1497.
24. Morrissey SP et al. (1993) The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study. Brain 116: 135-146.
25. Optic Neuritis Study Group. (1997) The 5-year risk of MS after optic neuritis. Experience of the optic neuritis treatment trial. Neurol 49: 1404-1413.
26. Riahi F et al. (1998) Improved correlation between scores on the expanded disability status scale and cerebral lesion load in relapsing-remitting multiple-sclerosis results of the application of new imaging methods. Brain 121: 1305-1312.
27. Gawne-Caine ML et al. (1998) MRI lesion volume measurement in multiple sclerosis and its correlations with disability a comparison of fast fluid attenuated inversion recovery (Fflair) and spin echo sequences. J Neurol Neurosurg Psych 64: 197-203.
28. Gass A et al. (1994) Correlation of magnetic transfer ratio with clinical disability in multiple sclerosis. Ann Neurol 36: 62-67.
29. Truyen L et al. (1996) Accumulation of hypointense lesions ('black holes') on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology 47: 1469-1476.
30. van Walderveen MA et al. (1998) Histopathological correlate of hypointense lesions on Tl-weighted spin-echo MRI in multiple sclerosis. Neurology 50: 1282-1288.
31. Losseff NA et al. (1996) Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. Brain 119: 2009-2019.
32. van Walderveen MA et al. (1995) Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images. Neurology 45: 1684-1690.
33. Barkhof F. (1997) Imaging of remyelination. Multiple Sclerosis 3: 129-132.
34. Simon JH et al. (1998) Magnetic resonance studies of intramuscular interferon beta-la for relapsing multiple sclerosis. Ann Neurol 43: 79-97.
35. Filippi M et al. (1995) Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study. Neurology 45: 255-260.